FDA: Page 91


  • Deep Dive

    Red states say 'yes' to Medicaid; DME gets boost in Nevada

    Three GOP-heavy states expanded Medicaid on Tuesday, and Democratic governor pickups in other parts of the country could further the trend. Elsewhere, durable medical equipment makers scored a win in Nevada.

    By Rebecca Pifer • Nov. 7, 2018
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Abbott, J&J take part in FDA's NEST real world evidence pilot

    The test cases will assess the role of RWE in proactive post-market surveillance, the evaluation of ablation devices and other activities across the medical device lifecycle.

    By Nov. 6, 2018
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendline
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • Pact to rush medical products for military clinched

    The memorandum signed by the FDA and Department of Defense formalizes a program to speed review of high-priority treatments for the military such as freeze-dried plasma.

    By Nov. 5, 2018
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    ACLA praises CMS for boosting data collection

    The clinical lab trade group lauded the agency for taking steps to increase the number of laboratories submitting data informing Medicare payment rates.

    By David Lim • Nov. 5, 2018
  • Image attribution tooltip
    Parker Johnson on Unsplash
    Image attribution tooltip
    Deep Dive

    Midterms 2018: Key health ballot votes in the states

    It's not just Congress up for grabs in Tuesday's midterm elections. From Medicaid expansion to dialysis treatments to nurse staffing ratios, here's a snapshot of key votes, the odds and what they could mean for the industry.

    By David Lim , Tony Abraham , Rebecca Pifer , Samantha Liss • Nov. 2, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS finalizes DME bidding program overhaul despite cost

    Administrator Seema Verma said the final rule will increase patient access to medical products, but an August GAO report found beneficiaries are able to get needed items under the current paradigm.

    By David Lim • Nov. 2, 2018
  • Image attribution tooltip
    Jacob Bell / BioPharma Dive
    Image attribution tooltip

    Patient deaths following Getinge device shutdowns prompt FDA warning

    The agency has reports of three patient deaths following intra-aortic balloon pump malfunctions.

    By Nov. 2, 2018
  • Image attribution tooltip
    Roche
    Image attribution tooltip

    FDA warns about Roche test after reports of patient strokes

    Two patients suffered serious injuries involving strokes, prompting a warning that inaccurate results from the Swiss pharma's CoaguChek could cause serious injuries or death when taken with the blood thinner warfarin.

    By Nov. 2, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer gets FDA nod for knee implant as portfolio strategy advances

    Clearance coincided with first use of the device maker's knee surgery robot. The CEO has been vague about how it will differentiate its knee and spine devices from rival products, such as those sold by Mazor Robotics and Stryker.

    By Nov. 1, 2018
  • 23andMe wins FDA clearance for first-of-its-kind genetic test

    The agency also sent a safety communication warning about the danger of relying on genetic tests that have not been reviewed by FDA making claims about patient response to individual medications.

    By David Lim , Nov. 1, 2018
  • A timeline of Anthem's bold payment policies (and the fallout)

    The payer's aggressive moves to push procedures like imaging to outpatient settings and taking a hard line on emergency room visits has drawn fire from doctors and other critics.​

    By Samantha Liss • Oct. 31, 2018
  • A picture of the exterior of the US Department of Health and Human Services. In front of the building is a black sign designating the building's name.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    HHS opens cybersecurity coordination center after troubled year

    It comes five months after a bipartisan group of lawmakers took HHS to task over stuttering attempts to coordinate cybersecurity information sharing.

    By Oct. 31, 2018
  • AdvaMed pitches new Anti-Kickback Statute safe harbors

    The trade group wants the carve-outs for value-based pricing, warranty and risk-sharing arrangements.

    By David Lim • Oct. 30, 2018
  • Deep Dive

    5 sticking points in the EU medical device reg transition

    Brexit and notified body capacity are among the uncertainties, as many in the medtech sector are uninformed.

    By Meg Bryant • Oct. 29, 2018
  • Speedy Medicare breakthrough device coverage plan slated for March

    AdvaMed has been pushing the agency to take steps to limit the delay between FDA approval and reimbursement. 

    By Oct. 26, 2018
  • Image attribution tooltip
    Elizabeth Regan/BioPharma Dive
    Image attribution tooltip

    Novarad augmented reality system for surgery clears FDA

    The OpenSight system is designed for use with Microsoft HoloLens technology.

    By Meg Bryant • Oct. 25, 2018
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medtronic's dose-controlling app for pain pump gets FDA nod

    The technology enables users to deliver doses on demand to cope with breakthrough pain.

    By Oct. 25, 2018
  • FDA clears Ansh Labs menopausal status test

    Physicians can use the results to inform actions to prevent osteoporosis and heart disease.

    By Oct. 25, 2018
  • Adverse events prompt FDA to advise monitoring of Alcon implants

    For now, the FDA says the problem looks to be limited to Alcon's implant. Glaukos markets a rival iStent device and saw its stock price increase by 40% when Alcon withdrew its stent.

    By Oct. 25, 2018
  • Image attribution tooltip
    MedImmune
    Image attribution tooltip

    LabCorp blames data breach, hurricane for substandard Q3

    The diagnostics branch was "particularly disappointing," said chairman and CEO Dave King.

    By Rebecca Pifer • Oct. 24, 2018
  • FDA starts 510(k) pilot to cut optical tomography processing times

    The program aims to give developers of optical coherence tomography devices the chance to discuss premarket performance testing recommendations with the agency.

    By Oct. 24, 2018
  • Medtronic's low-profile thoracic endograft gets FDA nod

    By expanding TEVAR to patients with a broader range of anatomies, Medtronic could gain an edge over rivals Bolton Medical, Cook Medical and Gore Medical.

    By Oct. 24, 2018
  • Viseon gets 510(k) clearance for spinal surgery device

    The product enables visualization of surgical sites during minimally-invasive procedures.

    By Oct. 19, 2018
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA sets busy year-end medical device to-do list

    Improving mammography quality, revamping the De Novo classification process and revising the definition of a medical device to exclude certain medical software are some of the agency's priorities.

    By David Lim • Oct. 19, 2018
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Stakeholders call for transparency, ease of use in EHR Reporting Program

    In comments, several healthcare organizations requested a centralized clearinghouse of existing health IT comparison resources.

    By Meg Bryant • Oct. 18, 2018